Replies to post #217105 on Biotech Values

[jbog]

It looks like there's ample room for Abbvie to increase sales. I'm not sure they had to lower the price like they did.

The providers are spending a fraction of what they were if our market share percentages are correct.

[DewDiligence]

GILD -5%/AH on 1Q18 results—HCV sales=$1.05B:

https://finance.yahoo.com/news/gilead-sciences-announces-first-quarter-200100189.html

Full-year 2018 guidance for revenue and non-GAAP EPS remain unchanged from the values given in February.